Literature DB >> 15286669

Blinking and superficial punctate keratopathy in patients with diabetes mellitus.

K Inoue1, K Okugawa, S Amano, T Oshika, E Takamura, F Egami, G Umizu, K Aikawa, S Kato.   

Abstract

AIM: To evaluate blinking patterns in patients with diabetes mellitus and whether blinking contributes to the formation of superficial punctate keratopathy in diabetic patients.
METHODS: We examined 163 patients with type II diabetes mellitus and 76 without diabetes. Blinks were recorded, analysed using six parameters, and compared between patients with and without diabetes. Multivariate regression analysis was performed to assess the influence of other ocular factors, such as status of tear lipid layer, tear breakup time, corneal sensitivity, the result of cotton thread test, or blinking rate related to superficial punctate keratopathy.
RESULTS: In patients with diabetes, the average mean and maximum interblinking times were longer, the average coefficient of variation of interblinking time was higher, and the average blinking rates were lower than those in patients without diabetes. Multivariate regression analysis revealed that the status of tear lipid layer and tear breakup time were significantly relevant to superficial punctate keratopathy (P < 0.01).
CONCLUSION: Interblinking time was longer in diabetic patients, resulting in a decreased blinking rate. The prevalence of superficial punctate keratopathy cannot be predicted from blinking patterns in patients with diabetes.

Entities:  

Mesh:

Year:  2005        PMID: 15286669     DOI: 10.1038/sj.eye.6701497

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  25 in total

1.  Ocular surface changes in type II diabetic patients with proliferative diabetic retinopathy.

Authors:  Yan Gao; Yan Zhang; Yu-Sha Ru; Xiao-Wu Wang; Ji-Zhong Yang; Chun-Hui Li; Hong-Xing Wang; Xiao-Rong Li; Bing Li
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

2.  Sensory nerve regeneration after epithelium wounding in normal and diabetic cornea.

Authors:  Fu-Shin Yu; Jia Yin; Patrick Lee; Frank S Hwang; Mark McDermott
Journal:  Expert Rev Ophthalmol       Date:  2015-06-26

3.  Corneal complications in streptozocin-induced type I diabetic rats.

Authors:  Jia Yin; Jenny Huang; Cynthia Chen; Nan Gao; Feng Wang; Fu-Shin X Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-22       Impact factor: 4.799

4.  Hyperglycemia-suppressed expression of Serpine1 contributes to delayed epithelial wound healing in diabetic mouse corneas.

Authors:  Haijing Sun; Xiaofan Mi; Nan Gao; Chenxi Yan; Fu-Shin Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

5.  Impaired epithelial wound healing and EGFR signaling pathways in the corneas of diabetic rats.

Authors:  Keping Xu; Fu-Shin X Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-17       Impact factor: 4.799

Review 6.  Diabetes mellitus is associated with dry eye syndrome: a meta-analysis.

Authors:  Tae Keun Yoo; Ein Oh
Journal:  Int Ophthalmol       Date:  2019-05-07       Impact factor: 2.031

7.  Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus.

Authors:  Ian S Zagon; Matthew S Klocek; Joseph W Sassani; Patricia J McLaughlin
Journal:  Arch Ophthalmol       Date:  2009-11

8.  Reduced innervation and delayed re-innervation after epithelial wounding in type 2 diabetic Goto-Kakizaki rats.

Authors:  Feng Wang; Nan Gao; Jia Yin; Fu-Shin X Yu
Journal:  Am J Pathol       Date:  2012-10-10       Impact factor: 4.307

9.  LL-37 via EGFR transactivation to promote high glucose-attenuated epithelial wound healing in organ-cultured corneas.

Authors:  Jia Yin; Fu-Shin X Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-24       Impact factor: 4.799

10.  High glucose may decrease the innate immune through TLRs in cornea epithelium.

Authors:  Hailong Ni; Xiaoran Yan; Zhenyun Lin; Xiuming Jin
Journal:  Mol Vis       Date:  2011-12-24       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.